2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidin-1-ium 2-propanamidobenzoate

被引:1
|
作者
Natarajan, Sampath [1 ]
Mathews, Rita [1 ]
机构
[1] Konkuk Univ, Dept Adv Technol Fus, Seoul 143701, South Korea
关键词
HYDROGEN-BONDING PATTERNS; ACID; 1/1; CRYSTAL;
D O I
10.1107/S1600536811035501
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
In the title salt, C12H14ClN4+center dot C10H10NO3-, zwitterionic N-H center dot center dot center dot O interactions form an R-2(2)(8) ring. The crystal structure is stabilized by N-H center dot center dot center dot O and N-H center dot center dot center dot N hydrogen bonds involving two different eight-membered rings. An N-H center dot center dot center dot O interaction occurs between the pyrimidine ring (donor) and carboxylate group (acceptor) while the other ring is formed by N-H center dot center dot center dot N interactions, which form a dimer between two symmetry-related salts. An intramolecular N-H center dot center dot center dot O hydrogen bond forms a six-membered ring in the benzoate. Intermolecular C-H center dot center dot center dot O interactions are also observed.
引用
收藏
页码:O2567 / U1789
页数:13
相关论文
共 50 条
  • [21] ELECTROCHEMICAL REDUCTION OF 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL)-6-CHLOROPYRIMIDINE
    VAJTNER, Z
    LOVRECEK, B
    JOURNAL OF ELECTROANALYTICAL CHEMISTRY, 1986, 213 (01) : 111 - 125
  • [22] 6-SUBSTITUTED 2,4-DIAMINO-5-(4-CARBETHOXYPHENYLAZO)PYRIMIDINES AS POTENTIAL PRECURSORS OF TETRAHYDROPTERIDINE ANTIMETABOLITES
    CHADWICK, M
    HAMPSHIR.J
    HEBBORN, P
    TRIGGLE, AM
    TRIGGLE, DJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1966, 9 (06) : 874 - &
  • [23] CLINICAL STUDIES OF 2,4-DIAMINO-5-(3'4'-DICHLOROPHENYL)-6-METHYLPYRIMIDINE (METOPRINE) WITH AND WITHOUT LEUCOVORIN
    CURRIE, VE
    KEMPIN, SJ
    SYKES, MP
    YOUNG, CW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 112 - 112
  • [24] SYNTHESIS OF 2 METABOLITES OF 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE (TRIMETHOPRIM)
    REYBELLET, G
    REINER, R
    HELVETICA CHIMICA ACTA, 1970, 53 (05) : 945 - +
  • [25] 4-(4-chlorophenyl)-5-[1-(4-chlorophenyl)-2-methyl-2-nitropropyl]-1,2,3-selenadiazole
    Marx, A.
    Saravanan, S.
    Muthusubramanian, S.
    Manivannan, V.
    Rath, Nigam P.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O349 - U1521
  • [26] CLINICAL USE OF DDMP (2,4-DIAMINO-5-(3'5' DICHLOROPHENYL)-6-METHYL PYRIMIDINE)
    PRICE, LA
    HILL, BT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 15 - 15
  • [27] METABOLISM AND EXCRETION OF 2,4-DIAMINO-5-(1-ADAMANTYL)-6-METHYLPYRIMIDINE(DAMP), A NEW ANTIFOLATE
    GIROTRA, RN
    GESSNER, T
    GREIZERTEIN, HB
    ZAKRZEWSKI, SF
    PHARMACOLOGIST, 1979, 21 (03): : 174 - 174
  • [28] 2-(4-Bromoanilino)-6-(4-chlorophenyl)-5-methoxycarbonyl-4-methyl-3,6-dihydropyrimidin-1-ium chloride
    Venugopala, K. N.
    Nayak, Susanta K.
    Odhav, Bharti
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O518 - +
  • [29] N-(4-Chlorophenyl)-2,4-dimethylbenzenesulfonamide
    Shakuntala, K.
    Foro, Sabine
    Gowda, B. Thimme
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2160 - U1641
  • [30] THE ANTIMALARIAL PROPERTIES OF 2,4-DIAMINO-5-PARA-CHLOROPHENYL-6-ETHYLPYRIMIDINE (DARAPRIM)
    SCHMIDT, LH
    GENTHER, CS
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1953, 107 (01): : 61 - 91